Published in Radiother Oncol on March 01, 1999
Lymph node ratio is more valuable than level III involvement for prediction of outcome in node-positive breast carcinoma patients. World J Surg (2007) 1.00
Post-mastectomy radiotherapy benefits subgroups of breast cancer patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis. Radiol Oncol (2014) 0.88
Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer. Ann Oncol (2008) 0.80
Prognostic factors affecting postmastectomy locoregional recurrence in patients with early breast cancer: are intrinsic subtypes effective? World J Surg (2011) 0.80
Is extracapsular tumour spread a prognostic factor in patients with early breast cancer? Int J Clin Oncol (2012) 0.79
Irradiation after surgery for breast cancer patients with primary tumours and one to three positive axillary lymph nodes: yes or no? Curr Oncol (2013) 0.79
Molecular Subtypes and Local-Regional Control of Breast Cancer. Surg Oncol Clin N Am (2018) 0.75
Prognostic significance of apex axillary invasion for locoregional recurrence and effect of postmastectomy radiotherapy on overall survival in node-positive breast cancer patients. World J Surg (2004) 0.75
Extended lymph-node dissection for gastric cancer. N Engl J Med (1999) 7.43
Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol (2004) 6.47
Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry (1998) 5.30
Risk of endometrial cancer after tamoxifen treatment of breast cancer. Lancet (1994) 4.38
Predictive value of signs and symptoms for colorectal cancer in patients with rectal bleeding in general practice. Fam Pract (1995) 3.82
Systematic review of enhanced recovery programmes in colonic surgery. Br J Surg (2006) 3.55
Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis. J Pathol (1999) 3.28
Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1998) 3.09
Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol (2000) 2.97
Glutamine and the preservation of gut integrity. Lancet (1993) 2.72
Development of a record linkage protocol for use in the Dutch Cancer Registry for Epidemiological Research. Int J Epidemiol (1990) 2.69
Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet (2001) 2.64
A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture. Cytometry (1996) 2.39
[Dutch Institute for Healthcare Improvement guideline, "Treatment of breast cancer"]. Ned Tijdschr Geneeskd (2002) 2.39
A systematic review of treatment modalities for primary basal cell carcinomas. Arch Dermatol (1999) 2.36
Prognostic significance of radial margins of clearance in rectal cancer. Br J Surg (1996) 2.15
A protocol is not enough to implement an enhanced recovery programme for colorectal resection. Br J Surg (2007) 2.11
Transient expression of phosphatidylserine at cell-cell contact areas is required for myotube formation. J Cell Sci (2001) 2.03
Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group. J Clin Oncol (1999) 1.98
Proliferating cell nuclear antigen (PCNA): a new marker to study human colonic cell proliferation. Gut (1994) 1.82
Age-specific differences in the diagnostics and treatment of cancer patients aged 50 years and older in the province of Limburg, The Netherlands. Ann Oncol (1996) 1.76
Flow cytometric determination of DNA ploidy level in nuclei isolated from paraffin-embedded tissue. Cytometry (1985) 1.73
A multivariate analysis of pathologic prognostic indicators in large bowel cancer. Cancer (1988) 1.72
Occurrence and clinical significance of overt blood loss per rectum in the general population and in medical practice. Br J Gen Pract (1994) 1.65
The joint association of air pollution and noise from road traffic with cardiovascular mortality in a cohort study. Occup Environ Med (2008) 1.63
The incidence and outcome of rectal bleeding in general practice. Fam Pract (1993) 1.62
[Adjuvant systemic therapy for patients with resectable breast cancer: guideline from the Dutch National Breast Cancer Platform and the Dutch Society for Medical Oncology]. Ned Tijdschr Geneeskd (2000) 1.59
Implementation of a short-stay programme after breast cancer surgery. Br J Surg (2010) 1.54
Sustainability of an enhanced recovery after surgery program (ERAS) in colonic surgery. World J Surg (2015) 1.53
The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. Radiother Oncol (2000) 1.53
Red and processed meat consumption and the risk of esophageal and gastric cancer subtypes in The Netherlands Cohort Study. Ann Oncol (2012) 1.49
Measurement of resting energy expenditure in a clinical setting. Clin Nutr (1990) 1.48
Endothelial intercellular adhesion molecule-1 expression is suppressed in human malignancies: the role of angiogenic factors. Cancer Res (1996) 1.42
Phase 1 study of rhenium-186-HEDP in patients with bone metastases originating from breast cancer. J Nucl Med (1996) 1.42
Use of resources and costs of palliative care with parenteral fluids and analgesics in the home setting for patients with end-stage cancer. Ann Oncol (1999) 1.42
[Nutrition and cancer: causative, protective and therapeutic aspects]. Ned Tijdschr Geneeskd (1999) 1.40
[Palliative treatment of bone metastases with bone-seeking radionuclides]. Ned Tijdschr Geneeskd (1998) 1.39
Cancer mortality trends in the EU and acceding countries up to 2015. Ann Oncol (2003) 1.38
Alcohol consumption, cigarette smoking and risk of subtypes of oesophageal and gastric cancer: a prospective cohort study. Gut (2010) 1.38
Muscular changes in the guinea pig caused by chronic ascorbic acid deficiency. J Neurol Sci (1991) 1.37
Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor-associated endothelium. Blood (1996) 1.35
Long-term quality of life of patients with head and neck cancer. Laryngoscope (2000) 1.32
Rising trends in the incidence of and mortality from cutaneous melanoma in the Netherlands: a Northwest to Southeast gradient? Eur J Cancer (2003) 1.32
Sociodemographic factors and quality of life as prognostic indicators in head and neck cancer. Eur J Cancer (2001) 1.30
An improved method for the immunocytochemical detection of bromodeoxyuridine labeled nuclei using flow cytometry. Cytometry (1987) 1.30
Effect of tissue fixation on anti-bromodeoxyuridine immunohistochemistry. J Histochem Cytochem (1987) 1.27
Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort. Gut (2005) 1.26
Expression pattern of the von Hippel-Lindau protein in human tissues. Lab Invest (1996) 1.25
Aromatase and COX-2 expression in human breast cancers. J Steroid Biochem Mol Biol (2001) 1.23
MIB-1 labelling index is an independent prognostic marker in primary breast cancer. Br J Cancer (1998) 1.21
Length of stay: an inappropriate readout of the success of enhanced recovery programs. World J Surg (2008) 1.19
Quality of life after palliative radiotherapy in non-small cell lung cancer: a prospective study. Int J Radiat Oncol Biol Phys (2000) 1.18
Lymphocytic infiltration in the spinal cord of patients with amyotrophic lateral sclerosis. Clin Neuropathol (1990) 1.16
Pneumonia due to Micrococcus spp. in a patient with acute myeloid leukaemia. Leukemia (1992) 1.15
Pretreatment factors predicting quality of life after treatment for head and neck cancer. Head Neck (2000) 1.13
Plasma membrane alterations and cytoskeletal changes in apoptosis. Exp Cell Res (1997) 1.13
Cancer in the very elderly Dutch population. Cancer (2000) 1.12
Cancer incidence in The Netherlands in 1989 and 1990: first results of the nationwide Netherlands cancer registry. Coordinating Committee for Regional Cancer Registries. Eur J Cancer (1995) 1.12
Internal mammary lymph drainage and sentinel node biopsy in breast cancer - A study on 1008 patients. Eur J Surg Oncol (2008) 1.11
Dose-dense epirubicin and paclitaxel with G-CSF: a study of decreasing intervals in metastatic breast cancer. Br J Cancer (2000) 1.11
Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer. Eur J Cancer (2005) 1.10
Cell kinetics of the marine sponge Halisarca caerulea reveal rapid cell turnover and shedding. J Exp Biol (2009) 1.10
A prospective study on quality of life of patients with cancer of the oral cavity or oropharynx treated with surgery with or without radiotherapy. Oral Oncol (1999) 1.08
Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU). Eur J Cancer (1999) 1.07
Prognostic significance of etiological risk factors in early breast cancer. Breast Cancer Res Treat (1997) 1.07
Mediastinal lymph node dissection in resected lung cancer: morbidity and accuracy of staging. Ann Thorac Surg (1993) 1.07
Age-specific differences in treatment and survival of patients with cervical cancer in the southeast of The Netherlands, 1986-1996. Eur J Cancer (2002) 1.06
Unexplained lymphadenopathy in family practice. An evaluation of the probability of malignant causes and the effectiveness of physicians' workup. J Fam Pract (1988) 1.04
Phosphatidylethanolamine mediates insertion of the catalytic domain of leader peptidase in membranes. FEBS Lett (1998) 1.04
Plasma-amino acid profiles in sepsis and stress. Ann Surg (1989) 1.03
Retrospective analysis of the prognostic significance of DNA content and proliferative activity in large bowel carcinoma. Cancer Res (1987) 1.03
CD44 is involved in tumor angiogenesis; an activation antigen on human endothelial cells. Blood (1997) 1.01
A core questionnaire for the assessment of patient satisfaction in academic hospitals in The Netherlands: development and first results in a nationwide study. Qual Saf Health Care (2010) 1.01
Long-term follow-up after open cholecystectomy. Br J Surg (1993) 1.00
Randomized, double-blind, controlled trial of acetylcysteine in amyotrophic lateral sclerosis. Arch Neurol (1995) 1.00
Preoperative assessment of local tumor extent in advanced rectal cancer: CT or high-resolution MRI? Abdom Imaging (2000) 1.00
Angiogenesis inhibitors overcome tumor induced endothelial cell anergy. Int J Cancer (1999) 1.00
A prospective study on quality of life of laryngeal cancer patients treated with radiotherapy. Head Neck (1999) 1.00
Reproductive and hormonal factors in association with ovarian cancer in the Netherlands cohort study. Am J Epidemiol (2010) 0.99
Phase II trial of mitomycin C (MMC) in advanced gallbladder and biliary tree carcinoma. An EORTC Gastrointestinal Tract Cancer Cooperative Group Study. Ann Oncol (1993) 0.99
Prospective study on quality of life before and after radical radiotherapy in non-small-cell lung cancer. J Clin Oncol (2001) 0.99
Gut permeability, intestinal morphology, and nutritional depletion. Nutrition (1998) 0.99
Massive haemoptysis after radiotherapy in inoperable non-small cell lung carcinoma: is endobronchial brachytherapy really a risk factor? Radiother Oncol (1998) 0.98
Glutamine appearance rate in plasma is not increased after gastrointestinal surgery in humans. J Nutr (2000) 0.98
Negative and positive influences of social support on depression in patients with head and neck cancer: a prospective study. Psychooncology (2000) 0.98
Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis--an EORTC STBSG and ROG study (EORTC 62991-22998). Ann Oncol (2013) 0.98
Radical resection of locally advanced colorectal cancer. Br J Surg (1995) 0.97
Estimation of body composition by bioelectrical impedance in cancer patients. Eur J Clin Nutr (1990) 0.97
Resting energy expenditure in patients with non-small cell lung cancer. Cancer (1991) 0.97
T3 laryngeal cancer: a retrospective study of the Dutch Head and Neck Oncology Cooperative Group: study design and general results. Clin Otolaryngol Allied Sci (1992) 0.97